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ABSTRACT
Reliable laboratory testing is important to detect Toxoplasma gondii infection 
and focuses on improving the low cost and easy to use the diagnostic 
instrument. Enzyme-linked immunosorbent assay (ELISA) method can be 
used to determine a large number of samples within a short period of time 
which based on antibody or antigen detection. We tested the sensitivity 
and specificity of GRA1 protein of as antigen using the ELISA method to 
toxoplasmosis diagnosis and compared it with commercial ELISA kit. Seventy 
sera samples were collected and tested using indirect ELISA, commercial 
ELISA kit and GRA1 protein-coated as antigen. The results showed 48 and 
51 samples had positive IgG antibody using ELISA-GRA1 and commercial 
ELISA kit, respectively. The GRA1 sensitivity and specificity on ELISA were 
100% and 86.36%, respectively. Whereas positive predictive value (PPV) was 
94.11%. This result indicated that the recombinant GRA1 protein is a highly 
immunogenic protein in human toxoplasmosis and marker for toxoplasmosis 
screening.
 
ABSTRAK
Pengujian laboratorium yang handal penting untuk mendeteksi infeksi 
Toxoplasma gondii dan berfokus untuk meningkatkan instrumen diagnosis 
yang murah dan mudah digunakan. Metode Enzyme-linked immunosorbent 
assay (ELISA) dapat digunakan untuk menguji sampel dalam jumlah besar 
dalam waktu singkat dan berdasarkan pada deteksi antibodi atau antigen. 
Kami menguji sensitifitas dan spesifisitas dari protein GRA1 sebagai antigen 
pada metode ELISA untuk mendiagnosis toxoplasmosis dan dibandingkan 
dengan commercial ELISA kit. Tujuh puluh sampel serum dikumpulkan dan 
diuji menggunakan indirect ELISA, ELISA kit komersial dan protein GRA1 
dilapisi sebagai antigen (ELISA-GRA1). Hasil penelitian menunjukkan, 48 
dan 51 sampel positif memiliki antibodi IgG berturut-turut menggunakan 
ELISA-GRA1 dan ELISA kit komersial. Sensitivitas dan spesivisitas dari 
ELISA-GRA1 adalah 100% and 86,36%, positive prediction value (PPV) adalah 
94,11%. Hasil ini menunjukkan protein GRA1 rekombinan adalah protein 
yang sangat imunogenik pada toksoplasmosis manusia dan marker untuk 
skrining toksoplasmosis.
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INTRODUCTION
Toxoplasmosis is a disease caused by 
infection of obligate protozoan parasite, 
called Toxoplasma gondii. Human can be 
infected by T.gondii through congenital 
toxoplasmosis, consumption habits 
(raw meats, raw vegetables), activity 
with soil/meat without protection, blood 
transfusion, organ transplantation, 
etc. Oocyst become infective stage 
when passed out from definitive host 
and contaminated water sources, soil 
and plants. Most of toxoplasmosis 
is asymptomatic but can be serious 
problems in immunocompromised 
patients and newborns with 
congenital toxoplasmosis. Effect of 
T.gondii infection caused encephalitis 
in immunocompormised hosts, 
chorioretinitis on immunocompetent 
hosts or seriously congenital disease on 
fetus development if pregnant women 
become infected for the first time during 
pregnancy.1 More than 60% world 
population are toxoplasmosis and 90% 
of it asymptomatic even they have T. 
gondii antibodies. It depends on the 
individual immune responses to prevent 
the symptoms.2 
Commonly, detection of 
toxoplasmosis using serological 
methods, such as a dye test (DT), modified 
agglutination test (MAT), enzyme-
linked immunosorbent assays (ELISA), 
immunosorbent agglutination assay 
(ISAGA), indirect fluorescent antibody 
test (IFAT) and indirect haemaglutination 
assays (IHA) to detect T. gondii antibody. 
Parasite demonstrates in tissue can be 
done by culturing of parasite (in vivo 
and in vitro) and detection of spesific 
nucleic acid using DNA probe, PCR 
and L-AMP methods. Enzyme-linked 
immunosorbent assays is a popular and 
easier method for detection of clinically 
toxoplasmosis and commercially 
available. Commercial ELISA kits using 
antigen from native tachyzoites which 
grown in mice or tissue culture and 
probably contain varying amounts of 
extraparasitic material.3 Limitations 
of the tachyzoite antigen for serologic 
tests can be serious problems, another 
antigens should become an alternative 
test, such as using purified recombinant 
antigens which expressed by tachyzoites 
and bradyzoites. However, the whole 
tachyzoite native antigen test is difficult to 
standardize and some cases produce false 
positive reactions.4 Tachyzoites is not the 
only component caused activation of the 
immune response to produce antibody, 
expression of excreted-secreted antigen 
from bradyzoites can induce antibody 
production and  IgG specific T. gondii 
which are always existed in an infected 
host lifetime.
GRA1 has been identified as excreted-
secreted antigen (ESA) in tachyzoites 
and cross-reactive with bradyzoites.5 
It located in the dense granule of both 
tachyzoites and bradyzoites and using as 
T. gondii secretory organelle marker. It 
always secreted in lumen and potentially 
can be identified in body fluid of the 
infected host. GRA1 can induce humoral 
and cellular immune responses in 
chronic infection phase such as increase 
production of antibody and IFN-γ on 
mice and humans. GRA1 epitope is 
presented on MHC class I molecules 
during infection and inducing specific 
CTLs.6-8 GRA-1 was secreted into the 
lumen of the parasitophorous vacuole 
as a soluble protein and associated 
with the membranous tubular network 
peripherally.9 GRA1 was needed for 
secretion of 3 secretory organelles 
of T. gondii and became a marker of 
dense granule proteins.10 GRA1 protein 
vaccination shows CD8+ T-cells activity 
against target cells infected with 
parasites and GRA1 transfected cell line.7
The costs of serologic test in developed 
countries is not prohibitively high and 
have low-cost alternative tests with the 
same sensitivity and specificity. The cost 
of developing the instrument depends 
on efficient production of recombinant 
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antigens.11 The previous study in the 
same project had been developing an 
efficient system for the production and 
purification of GRA1 proteins and had 
tested for immunogenic activity. Based 
on the ability of GRA1 to stimulated 
immune response, we tried its ability as 
antigens to develop the diagnostic tools. 
Sensitivity and specificity of GRA1 as 
antigens in ELISA methods (ELISA-GRA1) 
compared to the commercial ELISA kit to 
the detection of IgG antibodies against T. 
gondii.
MATERIALS AND METHODS
Total of 70 human sera were obtained 
from a previous study in Central Java 
population and approved by Medical 
and Health Research Ethic Committee, 
Faculty of Medicine, Public Health and 
Nursing, Universitas Gadjah Mada for 
study in human subject.12 Sera was tested 
using ELISA methods and separated 
for ELISA kit test and ELISA-GRA1 
coated protein as antigen. Preparation 
of recombinant protein GRA1 consists 
of isolation, characterization, cloning, 
expression and purification of GRA1 
protein. Isolation, characterization, 
cloning and expression of GRA1 protein 
were carried by previous researcher in 
same project 13,14 and the stored culture 
of E. coli inserted with GRA1 protein 
in 4°C until we used for this study. The 
recombinant E. coli was recultured and 
isolated GRA1 protein used to sonication 
for breaking the bacterial membrane. 
Purification of GRA1 protein using Ni-
ted profino column chromatography and 
electrophoresis to confirmed the result. 
Protein recombinant GRA1 was used 
as antigen and coated overnight at 37°C 
using coating buffer (1:10). Dilution of 
human sera and anti-human IgG alkaline 
phosphatase were conjugated 10 times 
and 5000 times, respectively. Human 
sera was added and incubated at 37°C 
at an hour. Washing solution was added 
3 times after each process to remove all 
unbounded particles. Antihuman IgG 
alkaline phosphatase, substrate and 
stop solution were added alternately 
to complete the methods and the 
quantitative result measured by ELISA 
reader. Cut off value was counted by 
mean of negative control. Seropositive 
of Tg-IgG antibodies measured by optical 
density and compared with cutoff value. 
Effectiveness of GRA1 as promising-
antigen was evaluated by ELISA kit 
commercial (GenWay BioTech) coated 
with native tachyzoites. Procedure of 
ELISA kit was followed the manual 
instruction. The kit consists of dilution 
buffer, washing buffer, negative and 
positive control, 4 types of calibrator 
to differentiate negative, low and high 
positive antibody concentration.
RESULTS
Serodiagnostic using recombinant 
proteins of T. gondii were evaluated 
by  ELISA-GRA1 and compared with 
commercial ELISA kit. Sensitivity 
and specificity were measured for 
effectiveness detection of GRA1 protein 
as antigen. The result of GRA1-ELISA 
showed 51 positive and 19 negative 
samples, while the result of ELISA kit 
showed 48 positive and 22 negative 
samples (TABLE 1).
TABLE 1. Sensitivity and specificity of recombinant protein GRA1
No. ELISA kit
Positive of IgG Negative of IgG Total
No. ELISA-GRA1
Positive of IgG 48 3 51
Negative of IgG 0 19 19
Total 48 22 70
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DISCUSSION
Commercial ELISA kit usually using 
native tachyzoites antigens coated in 
microplate and worldwide distribution 
to toxoplasmosis diagnosis. This tool 
is a high-cost instrument among 
laboratories and not always accurate 
because often produces false positive 
reactions.4 Toxoplasmosis diagnosis is 
an important test for human in every 
social-economic status, development of 
low-cost diagnostic tools are seriously 
important to supporting of health 
status and epidemiological screening in 
infectious disease in populations. 
The result of this study explicitly 
showed GRA1 antigen in ELISA was 
suitabled for detection of serum 
antibody to T. gondii infections and 
clearly distinguished mean OD and 95% 
CI. The method was able to differentiate 
of seropositive and seronegative on T. 
gondii-IgG sera. The test of GRA1-ELISA 
showed 51 positive and 19 negative 
samples, while there were 48 positive 
and 22 negative samples tested by ELISA 
kit (GenWay BioTech).
All estimation of sensitivity and 
specificity observation were greater 
than 80%. Sensitivity of GRA1 is 100% 
and specificity reaches 86.36%. Based 
on 80% of sensitivity and specificity, the 
observed sample size was sufficient to 
estimate good sensitivity and specificity 
as diagnostic tools. 
Dense granule proteins function 
is to manage modification of 
parasitophorous vacuole and intake 
nutrition from the cytoplasm of the 
infected cell.5,15-18 Modification needed 
for tachyzoites development in infected 
cell and replication of parasites on 
parasitophorous vacuole membrane.18 
Most of dense granule proteins secreted 
in parasitophorous vacuoles and 
increased following the number of 
parasite infections. A molecule became 
potential antigen if have foreigness in 
the body a consist of molecule weigh 
over 1kD, complex structure and stabil 
molecules.19 GRA1 protein have been 
reported have immunogenic and 
antigenic activity.6,7,20 Vercammen et al.6 
reported the result of GRA1 vaccination 
induce humoral immune response 
in mice and produce IgG antibodies. 
Naturally, GRA1 in parasitophorous 
vacuoles lumen induce secretion of IgG 
spesific antibodies to GRA1 and can be 
diagnosed using recombinant proteins 
GRA1 and serologic methods with sera 
as samples. 
However, there is a significant 
advantage on preparation of recombinant 
proteins than the preparation of crude T. 
gondii  proteins. Recombinant T. gondii 
proteins can be produced economically 
in large quantities with  in vitro E. coli 
culture, but crude T. gondii antigens 
must be extracted from T. gondii on 
animal models. Crude extracts contain 
large amounts of proteins, other 
macromolecules and most of them can 
affect test results.21 
Purification of recombinant 
protein is an alternative to detection 
of serum antibodies and allow better 
standardization of immunoassays.21-23 
Furthermore, use combination of 
recombinant antigens may enhance 
the sensitivity of antibody-based assay. 
Several previous studies have found 
that recombinant antigens improve 
the serological diagnosis of T. gondii 
infection.22-26 Moreover, recombinant 
antigens have the potential to be used 
to create new tests that can distinguish 
newly acquired infections from those 
obtained in the past.
CONCLUSSION
Our study showed high sensitivity 
and specificity of recombinant protein 
GRA1 as antigens for detections of 
toxoplasmosis using ELISA and specificity 
of GRA1 on ELISA are 100 and 86.36% to 
toxoplasmosis diagnosis.
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